Family Medicine·Sayre, PA

Robert Packer Hospital/Guthrie

Signal lift64%86%+22 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
220–256
p10 – p90
Sample N
1,520
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.3%
5 of 137 applicants
01Cohort funnelthis cycle
N = 1,520
Applied
1,520
100.0%
Invited
137
9%
Class size
5
0.3%
J-1 visaH-1B visaDO recognizedCategorical
Your fitRobert Packer Hospital/Guthrie Program

Create a free profile to see your personalized fit

Get started
Contact
MN
Program Director
Michelle Nanda, MD
Email director
SS
Program Coordinator
Suzanne Sinsasbaugh
Email coordinator
Training sites2 hospitals
  • 1
    Robert Packer Hospital
    Sayre, PA
    Primary
  • 2
    University of Rochester Medical Center
    Rochester, NY
    Participant
Score rangesinvited cohort
USMLE Step 2 CK220256
180205230255280
COMLEX Level 2 CE423611
400500600700800
Interview rates
US MD
47%
US DO
46%
US IMG
7%
Non-US IMG
6%
Applicant origin
In-state
44%
Out-of-state
8%
Interview prepFamily Medicine
specialtyWhat attracts you to the breadth of family medicine?★ common
programRural vs urban practice — what's your preference?
clinicalHow do you approach continuity of care?
specialtyTell me about procedures you'd like to incorporate into your practice.
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesFamily Medicine · 25-26
Save this program

Add Robert Packer Hospital/Guthrie to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Family Medicine.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.